Anti-obesity medications are often used to help people who have tried and not been able to lose enough weight through exercise and dietary changes. Obesity is a widespread issue affecting over 40% ...
The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...
Some anti-obesity medications, including GLP-1s ... It’s probably too soon to add substance use treatment to that list of ...
A controversial anti-obesity drug is set to become more widely available on the NHS. Orlistat, otherwise known as Xenical, has been prescribed free to some obese patients for the past two years.
The city claims that removing these drugs from its employee health plan will save money. In reality, it will have the opposite effect. The less we do to combat obesity, the more we have to spend ...
As anti-obesity medications gain popularity, a new concern has also gained traction among researchers: increased food waste. A self-administered online survey sponsored by Ohio State found that 25 ...
The proposed new rule issued by the Centers for Medicare and Medicaid Services would reinterpret the statutory regulation to “permit coverage of anti-obesity medications.” The administration ...
Two of the leading experts on anti-obesity drugs say the drugs are heralding a new era in medicine and could soon be used to treat a raft of other conditions. David Ricks, the chair and chief ...
The Biden administration has unveiled a major proposal to expand Medicare and Medicaid coverage for anti-obesity drugs, reflecting a shift in the perception of obesity as a chronic disease rather ...
In addition, the decline in overall obesity rate reported by the CDC isn’t the first such drop. Between 1999 and 2018, the NHANES results found two instances of slight decreases in obesity rates and ...
On Tuesday, November 26, the Centers for Medicare and Medicaid Services (CMS) proposed a new statutory interpretation that, if finalized, would result in expanded Medicare and Medicaid coverage for ...